Calcium,its Agonists and Antagonists: Past,Present and Future

Ringer S. . Concerning the influence exerted by each of the constituents of the blood on the contraction of the ventricle. J Physiol 1882; 3: 195–202

Ringer S. . A further contribution regarding the influence of the different constituents of the blood on the contraction of the heart. J Physiol 1883; 4: 29–42

Cheung W.Y. . Cyclic 3'5’ nucleotide phosphodiesterase. Demonstration of an activator. Biochem Biophys Res Commun 1970; 38: 533–8

Kakiuchi S. , Yamazaki R. , Nakajima H. . Calcium dependent phosphodiesterase activity and its activating factor. Proceedings of the Japan Academy Series B 1970; 46: 587–91

Fleckenstein A. . History of calcium antagonists. Circ Res 1983; 52(Suppl 1): 3–16

Reuter H. , Beeler G.W. . Calcium current and activation of contraction in ventricular myocardial fibres. Science 1969; 162: 399–401

Schramm M. , Towart R. . Modulation of calcium channel function by drugs. Life Sci 1985; 37: 1843–60

Zelis R. , Flaim S.F. . Calcium influx blockers and vascular smooth muscle: do we really understand the mechanisms? Ann Intern Med 1981; 94: 124–6

Weishaar R.E. . Calcium antagonists and calcium agonists: Is there a place in pharmacology for these two misnomers? Life Sci 1984; 35: 455–62

Lipkin D. , Poole-Wilson P.A. . Effect of nicardipine on myocardial contractility and on angina induced by atrial pacing in patients with coronary artery disease. Postgrad Med J 1984; 60(Suppl 4): 21–2 (abstract)

So S.Y. , Ip M. , Lam W.K. . Calcium channel blockers and asthma. Lung 1986; 164: 1–16

Deshpande J.K. , Wielock T. . Flunarizine, a calcium entry blocker, ameliorates ischemic brain damage in the rat. Anesthesiology 1986; 64: 215–24

Fleckenstein A. . Calcium antagonism in heart and smooth muscle. New York: John Wiley, 1983

Henry P.D. . Calcium antagonists and cardiovascular disease. New York: Raven Press, 1984